Skip to content

TBI

by Abbott Laboratories 510(k)

Active United States

510(k) K232669

Overview

The TBI is a traumatic brain injury assessment test that detects brain trauma without the need for a CT scan. This device provides faster results and is designed to be used in medical settings for evaluating patients with suspected traumatic brain injuries.

The TBI test is supplied for use in laboratory settings and runs on Abbott's Alinity i and Architect i1000SR laboratory instruments. It is authorized under FDA 510K clearance with product code QAT and is classified as a Class II medical device. The device is intended for use in major hospitals and laboratories for the assessment of traumatic brain injuries.

AI-generated from registry data, 24 Sep 2026.Not verified by deviCERTS or the manufacturer

Regulatory status

as of 26 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Special NumberK232669 Date29 Sep 2023ClearedStatusActive

Coverage

1 jurisdiction

United States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

United States — FDA 510(k) Active

Recalls: none on record (FDA, checked 6 Oct 2026)

Specification

510(k)

510(k) Number
FDA Product Code
QAT
Device Class
Class II
Regulation
21 CFR Part 866.5830
Advisory Committee
Immunology
FDA Decision
SESE Substantially Equivalent

Other devices from Abbott Laboratories

See all devices from Abbott Laboratories →

Questions

  • What is the TBI test used for?

    The TBI is a traumatic brain injury assessment test designed to detect brain trauma without requiring a CT scan. It provides faster results and is intended for use in medical settings for evaluating patients with suspected traumatic brain injuries.

  • How is the TBI test supplied and what instruments does it run on?

    The TBI test is supplied for use in laboratory settings and runs specifically on Abbott's Alinity i and Architect i1000SR laboratory instruments. It is designed for use in major hospitals and laboratories for the assessment of traumatic brain injuries.

  • What is the regulatory classification of the TBI test?

    The TBI test is authorized under FDA 510K clearance with product code QAT and is classified as a Class II medical device. It received FDA clearance on September 29, 2023, with decision code SESE indicating it is substantially equivalent to other devices.

  • Is the TBI test single-use or reusable?

    The device information does not specify whether the TBI test is single-use or reusable. As a laboratory test, it may be designed for single-use applications to ensure accuracy and prevent cross-contamination, but this detail is not explicitly stated in the provided data.